JP2003501030A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003501030A5 JP2003501030A5 JP2001500763A JP2001500763A JP2003501030A5 JP 2003501030 A5 JP2003501030 A5 JP 2003501030A5 JP 2001500763 A JP2001500763 A JP 2001500763A JP 2001500763 A JP2001500763 A JP 2001500763A JP 2003501030 A5 JP2003501030 A5 JP 2003501030A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- seq
- binding compound
- amino acid
- residues
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920001184 polypeptide Polymers 0.000 description 24
- 102000004196 processed proteins & peptides Human genes 0.000 description 24
- 108090000765 processed proteins & peptides Proteins 0.000 description 24
- 150000001875 compounds Chemical class 0.000 description 18
- 125000003275 alpha amino acid group Chemical group 0.000 description 14
- 102000039446 nucleic acids Human genes 0.000 description 13
- 108020004707 nucleic acids Proteins 0.000 description 13
- 150000007523 nucleic acids Chemical class 0.000 description 13
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 7
- 239000000203 mixture Substances 0.000 description 4
- 239000000427 antigen Substances 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000003937 drug carrier Substances 0.000 description 2
- 239000013604 expression vector Substances 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 230000035479 physiological effects, processes and functions Effects 0.000 description 2
- 241000238631 Hexapoda Species 0.000 description 1
- 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 1
- 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
- 102000017727 Immunoglobulin Variable Region Human genes 0.000 description 1
- 108010067060 Immunoglobulin Variable Region Proteins 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32291399A | 1999-06-01 | 1999-06-01 | |
| US09/322,913 | 1999-06-01 | ||
| PCT/US2000/014867 WO2000073451A1 (en) | 1999-06-01 | 2000-05-30 | Mammalian receptor proteins; related reagents and methods |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007138388A Division JP2007269802A (ja) | 1999-06-01 | 2007-05-24 | 哺乳動物レセプタータンパク質；関連する試薬および方法 |
| JP2011147648A Division JP2011188871A (ja) | 1999-06-01 | 2011-07-01 | 哺乳動物レセプタータンパク質；関連する試薬および方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2003501030A JP2003501030A (ja) | 2003-01-14 |
| JP2003501030A5 true JP2003501030A5 (https=) | 2007-07-12 |
| JP5643469B2 JP5643469B2 (ja) | 2014-12-17 |
Family
ID=23256988
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001500763A Expired - Fee Related JP5643469B2 (ja) | 1999-06-01 | 2000-05-30 | 哺乳動物レセプタータンパク質；関連する試薬および方法 |
| JP2007138388A Pending JP2007269802A (ja) | 1999-06-01 | 2007-05-24 | 哺乳動物レセプタータンパク質；関連する試薬および方法 |
| JP2011147648A Pending JP2011188871A (ja) | 1999-06-01 | 2011-07-01 | 哺乳動物レセプタータンパク質；関連する試薬および方法 |
| JP2014204554A Pending JP2015007129A (ja) | 1999-06-01 | 2014-10-03 | 哺乳動物レセプタータンパク質；関連する試薬および方法 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007138388A Pending JP2007269802A (ja) | 1999-06-01 | 2007-05-24 | 哺乳動物レセプタータンパク質；関連する試薬および方法 |
| JP2011147648A Pending JP2011188871A (ja) | 1999-06-01 | 2011-07-01 | 哺乳動物レセプタータンパク質；関連する試薬および方法 |
| JP2014204554A Pending JP2015007129A (ja) | 1999-06-01 | 2014-10-03 | 哺乳動物レセプタータンパク質；関連する試薬および方法 |
Country Status (13)
| Country | Link |
|---|---|
| EP (3) | EP2258849A1 (https=) |
| JP (4) | JP5643469B2 (https=) |
| AT (1) | ATE424456T1 (https=) |
| AU (1) | AU5305300A (https=) |
| CA (1) | CA2374391C (https=) |
| CY (1) | CY1109093T1 (https=) |
| DE (1) | DE60041697D1 (https=) |
| DK (1) | DK1181366T4 (https=) |
| ES (1) | ES2322791T5 (https=) |
| MX (1) | MXPA01012331A (https=) |
| PT (1) | PT1181366E (https=) |
| SI (1) | SI1181366T2 (https=) |
| WO (1) | WO2000073451A1 (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1942114A3 (en) * | 1999-03-11 | 2008-08-27 | Schering Corporation | Mammalian cytokines; related reagents and methods |
| SI1181366T2 (sl) | 1999-06-01 | 2013-10-30 | Merck Sharp & Dohme Corp. | Sesalski receptorski proteini; sorodni reagenti in postopki |
| ATE455852T1 (de) | 1999-06-02 | 2010-02-15 | Chugai Pharmaceutical Co Ltd | Neues hämopoietin rezeptorprotein nr10 |
| AU2007202362B2 (en) * | 1999-09-03 | 2011-06-23 | Merck Sharp & Dohme Corp. | Mammalian receptor proteins; related reagents and methods |
| WO2001023556A1 (en) * | 1999-09-27 | 2001-04-05 | Chugai Seiyaku Kabushiki Kaisha | Novel hemopoietin receptor protein, nr12 |
| CA2408571C (en) | 2000-05-10 | 2014-04-29 | Schering Corporation | Mammalian receptor proteins; related reagents and methods |
| US7422743B2 (en) | 2000-05-10 | 2008-09-09 | Schering Corporation | Mammalian receptor protein DCRS5;methods of treatment |
| CA2412239C (en) | 2000-06-26 | 2013-05-28 | Zymogenetics, Inc. | Cytokine receptor zcytor17 |
| AU2003280410B8 (en) | 2002-01-18 | 2009-04-23 | Zymogenetics, Inc. | Cytokine receptor zcytor17 multimers |
| WO2007142325A1 (ja) | 2006-06-08 | 2007-12-13 | Chugai Seiyaku Kabushiki Kaisha | 炎症性疾患の予防または治療剤 |
| TWI426918B (zh) | 2007-02-12 | 2014-02-21 | Merck Sharp & Dohme | Ｉｌ-２３拮抗劑於治療感染之用途 |
| CN104162155A (zh) | 2007-12-05 | 2014-11-26 | 中外制药株式会社 | 搔痒症治疗药 |
| GB0915220D0 (en) * | 2009-09-02 | 2009-10-07 | Summers Shauna | Method and apparatus for forming holes in a hollow tubular body |
| CN108949716A (zh) * | 2018-06-22 | 2018-12-07 | 青岛中科爱博生物科技有限公司 | 一种热启动Taq DNA聚合酶的制备方法 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2031216A1 (de) | 1969-06-19 | 1971-01-14 | Citizen Watch Co Ltd , Tokio | Tag und Datum Stellvorrichtung fur Uhren mit Kalender |
| US3940475A (en) | 1970-06-11 | 1976-02-24 | Biological Developments, Inc. | Radioimmune method of assaying quantitatively for a hapten |
| NL154598B (nl) | 1970-11-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking. |
| US3817837A (en) | 1971-05-14 | 1974-06-18 | Syva Corp | Enzyme amplification assay |
| US3939350A (en) | 1974-04-29 | 1976-02-17 | Board Of Trustees Of The Leland Stanford Junior University | Fluorescent immunoassay employing total reflection for activation |
| US3996345A (en) | 1974-08-12 | 1976-12-07 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
| US4277437A (en) | 1978-04-05 | 1981-07-07 | Syva Company | Kit for carrying out chemically induced fluorescence immunoassay |
| US4275149A (en) | 1978-11-24 | 1981-06-23 | Syva Company | Macromolecular environment control in specific receptor assays |
| US4366241A (en) | 1980-08-07 | 1982-12-28 | Syva Company | Concentrating zone method in heterogeneous immunoassays |
| US4659678A (en) | 1982-09-29 | 1987-04-21 | Serono Diagnostics Limited | Immunoassay of antigens |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4859609A (en) | 1986-04-30 | 1989-08-22 | Genentech, Inc. | Novel receptors for efficient determination of ligands and their antagonists or agonists |
| US5789192A (en) | 1992-12-10 | 1998-08-04 | Schering Corporation | Mammalian receptors for interleukin-10 (IL-10) |
| US5716804A (en) * | 1995-04-19 | 1998-02-10 | Schering Corporation | Mammalian interleukin-10 (IL-10) super-activating receptors; and variants |
| GB9721961D0 (en) | 1997-10-16 | 1997-12-17 | Glaxo Group Ltd | Novel molecules |
| SI1181366T2 (sl) | 1999-06-01 | 2013-10-30 | Merck Sharp & Dohme Corp. | Sesalski receptorski proteini; sorodni reagenti in postopki |
| WO2001023556A1 (en) * | 1999-09-27 | 2001-04-05 | Chugai Seiyaku Kabushiki Kaisha | Novel hemopoietin receptor protein, nr12 |
| US11068393B2 (en) | 2019-10-17 | 2021-07-20 | Microsoft Technology Licensing, Llc | Enhanced concurrency garbage collection stack scanning |
-
2000
- 2000-05-30 SI SI200031025T patent/SI1181366T2/sl unknown
- 2000-05-30 EP EP10179559A patent/EP2258849A1/en not_active Withdrawn
- 2000-05-30 ES ES00937943T patent/ES2322791T5/es not_active Expired - Lifetime
- 2000-05-30 MX MXPA01012331A patent/MXPA01012331A/es active IP Right Grant
- 2000-05-30 PT PT00937943T patent/PT1181366E/pt unknown
- 2000-05-30 DK DK00937943.9T patent/DK1181366T4/da active
- 2000-05-30 EP EP08103122A patent/EP1950299A1/en not_active Withdrawn
- 2000-05-30 EP EP00937943.9A patent/EP1181366B2/en not_active Expired - Lifetime
- 2000-05-30 JP JP2001500763A patent/JP5643469B2/ja not_active Expired - Fee Related
- 2000-05-30 WO PCT/US2000/014867 patent/WO2000073451A1/en not_active Ceased
- 2000-05-30 AU AU53053/00A patent/AU5305300A/en not_active Abandoned
- 2000-05-30 CA CA2374391A patent/CA2374391C/en not_active Expired - Fee Related
- 2000-05-30 AT AT00937943T patent/ATE424456T1/de active
- 2000-05-30 DE DE60041697T patent/DE60041697D1/de not_active Expired - Lifetime
-
2007
- 2007-05-24 JP JP2007138388A patent/JP2007269802A/ja active Pending
-
2009
- 2009-05-25 CY CY20091100555T patent/CY1109093T1/el unknown
-
2011
- 2011-07-01 JP JP2011147648A patent/JP2011188871A/ja active Pending
-
2014
- 2014-10-03 JP JP2014204554A patent/JP2015007129A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111690059B (zh) | 一种抗SARS-CoV-2的单克隆抗体1D7 | |
| CN113354729B (zh) | 一种抗新型冠状病毒的单克隆抗体及其应用 | |
| JP2003501030A5 (https=) | ||
| JP2003534013A5 (https=) | ||
| JPWO2019173291A5 (https=) | ||
| CN115461368A (zh) | 抗人白细胞介素-4受体α抗体及其制备方法和应用 | |
| JP2005518336A5 (https=) | ||
| JP2020505927A5 (https=) | ||
| CN113354730B (zh) | 一种抗新型冠状病毒的单克隆抗体及其应用 | |
| JP2011505810A5 (https=) | ||
| CN105026425A (zh) | 抗颗粒溶解素抗体、方法及其应用 | |
| CN111732654A (zh) | 一种抗SARS-CoV-2的单克隆抗体1E10 | |
| WO1986004336A1 (en) | Monoclonal antibodies against core proteins of lymphadenopathy-associated-viruses | |
| CN106928363B (zh) | 一种FAP纳米抗体Nb12 | |
| CN104119437A (zh) | 具有抗绿脓杆菌作用的人源化PcrV抗体 | |
| JPH11127861A (ja) | Ｃ型肝炎ウイルス由来のセリンプロテアーゼに対する中和抗体部分ペプチド | |
| US20210353733A1 (en) | Vaccine and antibody against clostridioides difficile toxin | |
| AU736287B2 (en) | Humanized anti-human Fas antibody | |
| CN106928364B (zh) | 一种FAP纳米抗体Nb26 | |
| CN106928365B (zh) | 一种FAP纳米抗体Nb36 | |
| WO2021238854A1 (zh) | 抗SARS-CoV-2刺突蛋白的单克隆抗体及其制备方法和用途 | |
| AU622446B2 (en) | A monoclonal antibody against pseudomonas aeruginosa, the preparation and use thereof | |
| CA3158138A1 (en) | Antibodies for binding plasminogen | |
| CN119019545A (zh) | 针对乳头瘤病毒18型e蛋白的单克隆抗体 | |
| CN115073595B (zh) | 广谱抗非典、新冠病毒及其突变株的纳米抗体aSA3 |